Pre-Tax Profit Margin: Earnings before taxes as a portion of total revenue. Calculated as: Pre-Tax Income / Total Revenues
Arbutus Biopharma Corporation (ABUS) had Pre-Tax Profit Margin of -357.37% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$1.05M |
|
$-3.76M |
|
-- |
|
$1.05M |
|
$6.34M |
|
$-5.29M |
|
$1.53M |
|
$-3.76M |
|
$-4.43M |
|
$-3.76M |
|
$-3.76M |
|
$-3.76M |
|
$-4.43M |
|
$-5.29M |
|
$-5.28M |
|
191.60M |
|
191.60M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$94.46M |
|
$0.03M |
|
$0.16M |
|
$94.62M |
|
$6.01M |
|
-- |
|
$12.04M |
|
$18.04M |
|
$76.58M |
|
$76.58M |
|
$76.58M |
|
192.53M |
|
| Cash Flow Statement Financials | |
$-39.64M |
|
$15.58M |
|
$5.72M |
|
$36.33M |
|
$18.01M |
|
$-18.32M |
|
$6.95M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
15.73 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-503.33% |
|
-503.33% |
|
-- |
|
|
Pre-Tax Profit Margin |
-357.37% |
-357.37% |
|
$-39.27M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
0.73 |
|
123.91 |
|
-4.90% |
|
-4.90% |
|
-3.97% |
|
-4.90% |
|
$0.40 |
|
$-0.20 |
|
$-0.21 |
|